HOME - Companies - News
 
 
24 August 2023

Dentognostics, backed by significant investments, seeks to improve periodontal disease outcomes


Dentognostics, a research-driven technology company, has secured significant investments from Dental Innovation Alliance and Dental365, which should propel the company's growth and innovation in the U.S. dental market.

With their patented products for oral health and wellness, Dentognostics has gained the trust and support of industry leaders. Notably, Pacific Dental Services made a major investment in 2021, partnering with the company to actively explore innovative technologies, including the tool to screen patients by taking a simple mouth rinse sample, within their supported practices.

Dentognostics seeks to empower patients with knowledge about what is happening in their mouth and with the understanding of the importance of proper dental hygiene, periodontal care and maintenance. According to a news release, this is done with a patented product that analyzes saliva to determine the collagen breakdown activity in the mouth. By providing patients with a quantitative Oral Fitness Score, the technology keeps the patients accountable for their daily home care behavior and allows the clinician to truly personalize the patients' care needs based on the data generated, ultimately developing trust between patients and their dental care provider.

Dental Innovation Alliance is a first-of-its-kind venture firm that funds, advises and propels the success of early-stage dental technology companies through its leadership and investor team, which has a combined more than 200 years of dental industry experience. Beyond capital, the alliance provides mentorship and connectivity that can enhance sales activity for portfolio companies.

"Supporting Dentognostics aligns perfectly with our mission at DIA, which is to foster innovation and collaboration in the dental and health sectors," said Thomas Sharpe, DIA Managing Partner, in the news release. "We firmly believe in the transformative power of Dentognostics' technology and see it as a game-changer in improving patient outcomes."

Joining PDS and DIA as an investor is Dr. Scott Asnis, DDS, CEO of Dental365, a full-service dental group with locations throughout New York, Connecticut, New Jersey, New Hampshire, Massachusetts and Rhode Island. This further underscores the widespread adoption potential of this technology within the U.S. dental market. 

Dirk-Rolf Gieselmann, Dentognostics founder and CEO, said the company is poised to revolutionize the oral health landscape and reach new heights.

About Dental Innovation Alliance

Dental Innovation Alliance (DIA) is a close group of dental industry executives that funds, advises and propels the success of early-stage companies building the future of dentistry through technology. Its investor base includes executives and experts from some of the largest and most innovative dental support organizations and other dental businesses. DIA has offices in New York, Nashville, and Raleigh-Durham.

Related articles

Penn Dental Medicine’s Kyle H. Vining and Hardik Makkar take a biomaterials approach to understanding periodontal disease, using a hydrogel system to investigate how the physical properties of the...


Inflammatory signaling pathway could become a therapeutic target


A translational study from the lab of Dr. Esra Sahingur shows “senotherapy” drug combination was effective in lab-dish and animal models.


Implementation of the new classification of periodontal diseases requires careful navigation of the new case definitions and organization of the diagnostic process along rationale and easily...


It is well established that dental plaque on teeth leads to gingivitis and periodontitis, and that several mechanical and chemical methods of plaque control can prevent gingivitis.


Read more

For a variety of reasons, orthodontic intervention is often overlooked as a viable modality to correct occlusal, axial, rotational, and space discrepancies before undertaking fixed prosthetic...


Congratulations to Ane Poly, D.D.S., M.Sc., Ph.D., a clinical assistant professor in the UF Department of Endodontics, who was recently chosen as the college’s representative to the Council of...


ONEDAYBIOTECH products garner honor as one of the 16th Annual Readers’ Choice Top 25 Implant Products


National leader in oral health integration and equity joins CareQuest Institute executive team.


Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, today announced its plan to reduce the size of its Board of...


 
 
 
 

 
 
 
 

Most popular

 
 

Events